{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:27:55Z","timestamp":1792758475218,"version":"4.5.0"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T00:00:00Z","timestamp":1627689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.biopha.2021.111990","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:11:54Z","timestamp":1628554314000},"page":"111990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":130,"special_numbering":"C","title":["Betulinic acid in the treatment of tumour diseases: Application and research progress"],"prefix":"10.1016","volume":"142","author":[{"given":"Wenkai","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wence","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.111990_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/nyas.13570","article-title":"Therapeutic applications of betulinic acid nanoformulations","volume":"1421","author":"Saneja","year":"2018","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.biopha.2021.111990_bib2","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.3892\/mmr.2016.5792","article-title":"Betulinic acid and the pharmacological effects of tumour suppression","volume":"14","author":"Zhang","year":"2016","journal-title":"Mol. Med Rep."},{"key":"10.1016\/j.biopha.2021.111990_bib3","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1111\/bph.13233","article-title":"Betulinic acid exerts anti-hepatitis C virus activity via the suppression of NF-\u03baB and MAPK-ERK1\/2-mediated COX-2 expression","volume":"172","author":"Lin","year":"2015","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2021.111990_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2006.04.006","article-title":"Pharmacological properties of the ubiquitous natural product botulin","volume":"29","author":"Alakurtti","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2021.111990_bib5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cyto.2014.09.004","article-title":"Betulinic acid attenuates lung injury by modulation of inflammatory cytokine response in experimentally-induced polymicrobial sepsis in mice","volume":"71","author":"Lingaraju","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.biopha.2021.111990_bib6","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/jps.2600650938","article-title":"Tumour inhibitory agents from Vauquelinia corymbosa (Rosaceae)","volume":"65","author":"Trumbull","year":"1976","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2021.111990_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2174\/138920112798868719","article-title":"Triterpenoids for cancer prevention and treatment: current status and future prospects","volume":"13","author":"Patlolla","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.biopha.2021.111990_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8781690","article-title":"Betulinic acid suppresses breast cancer metastasis by targeting GRP78-mediated glycolysis and ER stress apoptotic pathway","volume":"2019","author":"Zheng","year":"2019","journal-title":"Oxid. Med Cell Longev."},{"key":"10.1016\/j.biopha.2021.111990_bib9","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1038\/cddis.2017.485","article-title":"Overaccumulation of p53-mediated autophagy protects against betulinic acid-induced apoptotic cell death in colorectal cancer cells","volume":"8","author":"Wang","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2021.111990_bib10","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1124\/mol.112.078485","article-title":"Betulinic Acid Decreases Specificity Protein 1 (Sp1) Level via Increasing the Sumoylation of Sp1 to Inhibit Lung Cancer Growth","volume":"82","author":"Hsu","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2021.111990_bib11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/onc.2015.102","article-title":"Betulinic acid induces a novel cell death pathway that depends on cardiolipin modification","volume":"35","author":"Potze","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2021.111990_bib12","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/nm1095-1046","article-title":"Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis","volume":"1","author":"Pisha","year":"1995","journal-title":"Nat. Med"},{"key":"10.1016\/j.biopha.2021.111990_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3835(01)00718-2","article-title":"Selective cytotoxicity of betulinic acid on tumour cell lines, but not on normal cells","volume":"175","author":"Zuco","year":"2002","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2021.111990_bib14","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.3390\/molecules17032939","article-title":"Alpha-Mangostin enhances betulinic acid cytotoxicity and inhibits cisplatin cytotoxicity on HCT 116 colorectal carcinoma cells","volume":"17","author":"Aisha","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2021.111990_bib15","doi-asserted-by":"crossref","first-page":"5182","DOI":"10.1158\/0008-5472.CAN-10-2016","article-title":"Combining betulinic acid and mithramycin a effectively suppresses pancreatic cancer by inhibiting proliferation, invasion, and angiogenesis","volume":"71","author":"Gao","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2021.111990_bib16","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2147\/IJN.S157391","article-title":"Poly(lactic- co-glycolic acid)-loaded nanoparticles of betulinic acid for improved treatment of hepatic cancer: characterization, in vitro and in vivo evaluations","volume":"13","author":"Kumar","year":"2018","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.biopha.2021.111990_bib17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1166\/jbn.2020.2888","article-title":"The antitumour activity of betulinic acid-loaded nanoliposomes against colorectal cancer in vitroand in vivo via glycolytic and glutaminolytic pathways","volume":"16","author":"Wang","year":"2020","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.biopha.2021.111990_bib18","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.3390\/molecules14062016","article-title":"Pentacyclic triterpene distribution in various plants - rich sources for a new group of multi-potent plant extracts","volume":"14","author":"J\u00e4ger","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2021.111990_bib19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/med.10053","article-title":"Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection","volume":"24","author":"Cichewicz","year":"2004","journal-title":"Med Res Rev."},{"key":"10.1016\/j.biopha.2021.111990_bib20","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.3390\/molecules13102482","article-title":"Variation of ursolic acid content in eight Ocimum species from northeastern Brazil","volume":"13","author":"Silva","year":"2008","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2021.111990_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-2007-967106","article-title":"Solubility studies of oleanolic acid and betulinic acid in aqueous solutions and plant extracts of Viscum album L","volume":"73","author":"J\u00e4ger","year":"2007","journal-title":"Planta Med."},{"key":"10.1016\/j.biopha.2021.111990_bib22","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1055\/s-2006-951723","article-title":"Physical, chemical and pharmacological characterization of a new oleogel-forming triterpene extract from the outer bark of birch (betulae cortex)","volume":"72","author":"Laszczyk","year":"2006","journal-title":"Planta Med."},{"key":"10.1016\/j.biopha.2021.111990_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2006.04.006","article-title":"Pharmacological properties of the ubiquitous natural product botulin","volume":"29","author":"Alakurtti","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2021.111990_bib24","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2174\/1871523018666190426152049","article-title":"Betulinic acid-azaprostanoid hybrids: synthesis and pharmacological evaluation as anti-inflammatory agents","volume":"19","author":"Khlebnicova","year":"2020","journal-title":"Antiinflamm Antiallergy Agents Med Chem."},{"key":"10.1016\/j.biopha.2021.111990_bib25","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2174\/0929867053202214","article-title":"Betulinic acid and its derivatives: a review on their biological properties","volume":"12","author":"Yogeeswari","year":"2005","journal-title":"Curr. Med Chem."},{"key":"10.1016\/j.biopha.2021.111990_bib26","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1039\/C6GC02641A","article-title":"Toward a benign strategy for the manufacturing of betulinic acid","volume":"19","author":"Ressmann","year":"2017","journal-title":"Green. Chem."},{"key":"10.1016\/j.biopha.2021.111990_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.foodchem.2012.07.088","article-title":"A novel one-step microbial transformation of betulin to betulinic acid catalysed by Cunninghamella blakesleeana","volume":"136","author":"Feng","year":"2013","journal-title":"Food Chem."},{"key":"10.1016\/j.biopha.2021.111990_bib28","doi-asserted-by":"crossref","first-page":"14763","DOI":"10.1371\/journal.pone.0014763","article-title":"Linking genotype and phenotype of Saccharomyces cerevisiae strains reveals metabolic engineering targets and leads to triterpene hyper-producers","volume":"6","author":"Madsen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2021.111990_bib29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev-arplant-050312-120229","article-title":"Triterpene biosynthesis in plants","volume":"65","author":"Thimmappa","year":"2014","journal-title":"Annu Rev. Plant Biol."},{"key":"10.1016\/j.biopha.2021.111990_bib30","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/nm1095-1046","article-title":"Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of Apoptosis","volume":"1","author":"Pisha","year":"1995","journal-title":"Nat. Med"},{"key":"10.1016\/j.biopha.2021.111990_bib31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1196\/annals.1363.015","article-title":"Autophagy","volume":"1066","author":"Kelekar","year":"2005","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.biopha.2021.111990_bib32","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/abbs\/gmz148","article-title":"Betulinic acid induces apoptosis of gallbladder cancer cells via repressing SCD1","volume":"52","author":"Wang","year":"2020","journal-title":"Acta Biochim Biophys. Sin."},{"key":"10.1016\/j.biopha.2021.111990_bib33","first-page":"758","article-title":"Hypoxia-inducible factors: master regulators of cancer progression, trends","volume":"2","author":"Schito","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2021.111990_bib34","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbrc.2020.01.031","article-title":"Suppression of HIF-1\u03b1 accumulation by betulinic acid through proteasome activation in hypoxic cervical cancer","volume":"523","author":"Kim","year":"2020","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.biopha.2021.111990_bib35","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ctm2.190","article-title":"Suppression of lncRNA MALAT1 by betulinic acid inhibits hepatocellular carcinoma progression by targeting IAPs via miR-22-3p","volume":"10","author":"Chen","year":"2020","journal-title":"Clin. Transl. Med"},{"key":"10.1016\/j.biopha.2021.111990_bib36","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/15384047.2018.1564562","article-title":"The functional roles of exosomes-derived long non-coding RNA in human cancer","volume":"20","author":"Chen","year":"2019","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.biopha.2021.111990_bib37","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000493962","article-title":"Long non-coding MALAT1 functions as a competing endogenous RNA to regulate vimentin expression by sponging mir-30a-5p in hepatocellular carcinoma","volume":"50","author":"Pan","year":"2018","journal-title":"Cell Physiol. Biochem"},{"key":"10.1016\/j.biopha.2021.111990_bib38","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1158\/1535-7163.MCT-12-0026","article-title":"Betulinic acid targets YY1 and ErbB2 through cannabinoid receptor-dependent disruption of microRNA-27a:ZBTB10 in breast cancer","volume":"11","author":"Liu","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2021.111990_bib39","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/s41419-018-0669-8","article-title":"Betulinic acid chemosensitizes breast cancer by triggering ER stress-mediated apoptosis by directly targeting GRP78","volume":"9","author":"Cai","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2021.111990_bib40","doi-asserted-by":"crossref","first-page":"21492","DOI":"10.1371\/journal.pone.0021492","article-title":"Suppression of STAT3 and HIF-1 alpha mediates anti-angiogenic activity of betulinic acid in hypoxic PC-3 prostate cancer cells","volume":"6","author":"Shin","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2021.111990_bib41","first-page":"1669","article-title":"Betulinic acid induces apoptosis by regulating PI3K\/Akt signaling and mitochondrial pathways in human cervical cancer cells","volume":"40","author":"Xu","year":"2017","journal-title":"Int J. Mol. Med"},{"key":"10.1016\/j.biopha.2021.111990_bib42","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.biopha.2016.10.018","article-title":"Multiple molecular targets in breast cancer therapy by betulinic acid","volume":"84","author":"Luo","year":"2016","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2021.111990_bib43","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/molecules22020264","article-title":"Betulinic acid-mediated apoptosis in human prostate cancer cells involves p53 and nuclear factor-kappa B (NF-\u03baB) pathways","volume":"22","author":"Shankar","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2021.111990_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2015.07.016","article-title":"p53-p66(shc)\/miR-21-Sod2 signaling is critical for the inhibitory effect of betulinic acid on hepatocellular carcinoma","volume":"238","author":"Yang","year":"2015","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.biopha.2021.111990_bib45","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41590-017-0013-y","article-title":"Oxeiptosis, a ROS-induced caspase-independent apoptosis-like cell-death pathway","volume":"19","author":"Holze","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2021.111990_bib46","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/s41422-018-0090-y","article-title":"Tom20 senses iron-activated ROS signaling to promote melanoma cell pyroptosis","volume":"28","author":"Zhou","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.biopha.2021.111990_bib47","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1021\/acs.chemrev.8b00626","article-title":"Reactive oxygen species (ROS)-based nanomedicine","volume":"119","author":"Yang","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biopha.2021.111990_bib48","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrd2761","article-title":"Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease","volume":"8","author":"Fraisl","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2021.111990_bib49","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1016\/j.bmc.2019.03.033","article-title":"Betulinic acid induces apoptosis and inhibits metastasis of human colorectal cancer cells in vitro and in vivo","volume":"27","author":"Zeng","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2021.111990_bib50","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5083158","article-title":"Betulinic acid induces ROS-dependent apoptosis and S-phase arrest by inhibiting the NF- \u03baB pathway in human multiple myeloma","volume":"2019","author":"Shen","year":"2019","journal-title":"Oxid. Med Cell Longev."},{"key":"10.1016\/j.biopha.2021.111990_bib51","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3390\/biom9070257","article-title":"Betulinic acid suppresses ovarian cancer cell proliferation through induction of apoptosis","volume":"9","author":"Lee","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2021.111990_bib52","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s13046-016-0457-1","article-title":"A piperazidine derivative of 23-hydroxy betulinic acid induces a mitochondria-derived ROS burst to trigger apoptotic cell death in hepatocellular carcinoma cells","volume":"35","author":"Yao","year":"2016","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.biopha.2021.111990_bib53","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2021.111990_bib54","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1186\/s12935-020-01526-y","article-title":"The role of extracellular vesicles in cholangiocarcinoma","volume":"20","author":"Bai","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.biopha.2021.111990_bib55","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.omto.2020.10.005","article-title":"Association of MicroRNA-21 with p53 at mutant sites R175H and R248Q, clinicopathological features, and prognosis of NSCLC","volume":"19","author":"Zhou","year":"2020","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.biopha.2021.111990_bib56","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/07357907.2015.1019676","article-title":"Abnormal expression of miR-21 and miR-95 in cancer stem-like cells is associated with radioresistance of lung cancer","volume":"33","author":"Zhang","year":"2015","journal-title":"Cancer Invest."},{"key":"10.1016\/j.biopha.2021.111990_bib57","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0092-8674(00)81871-1","article-title":"p53, the cellular gatekeeper for growth and division","volume":"88","author":"Levine","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2021.111990_bib58","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0092-8674(94)90235-6","article-title":"Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway","volume":"77","author":"Akira","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2021.111990_bib59","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/s41422-018-0080-0","article-title":"STAT3 associates with vacuolar H +-ATPase and regulates cytosolic and lysosomal pH","volume":"28","author":"Liu","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.biopha.2021.111990_bib60","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ccell.2019.10.002","article-title":"A potent and selective small-molecule degrader of STAT3 achieves complete tumour regression in vivo","volume":"36","author":"Bai","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2021.111990_bib61","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000087907","article-title":"The possiblerole of the Jak\/STAT pathway in lymphocytes at the fetomaternal interface","volume":"89","author":"Poehlmann","year":"2005","journal-title":"Chem. Immunol. Allergy"},{"key":"10.1016\/j.biopha.2021.111990_bib62","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.vph.2005.08.021","article-title":"JANUS under stress--role of JAK\/STAT signaling pathway in vascular diseases","volume":"43","author":"Grote","year":"2005","journal-title":"Vasc. Pharm."},{"key":"10.1016\/j.biopha.2021.111990_bib63","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s40199-020-00336-x","article-title":"A new sesquiterpenoid from the shoots of Iranian Daphne mucronata Royle with selective inhibition of STAT3 and Smad3\/4 cancer-related signaling pathways","volume":"28","author":"Ghanadian","year":"2020","journal-title":"Daru"},{"key":"10.1016\/j.biopha.2021.111990_bib64","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5180707","article-title":"Helicteric acid, oleanic acid, and betulinic acid, three triterpenes from helicteres angustifolia l., inhibit proliferation and induce apoptosis in HT-29 colorectal cancer cells via suppressing NF- \u03baB and STAT3 signaling","volume":"2017","author":"Su","year":"2017","journal-title":"Evid. Based Complement Altern. Med"},{"key":"10.1016\/j.biopha.2021.111990_bib65","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc2403","article-title":"VEGF-targeted therapy: mechanisms of anti-tumour activity","volume":"8","author":"Ellis","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2021.111990_bib66","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.3727\/096504017X14841698396784","article-title":"Betulinic acid inhibits cell proliferation in human oral squamous cell carcinoma via modulating ROS-regulated p53 signaling","volume":"25","author":"Shen","year":"2017","journal-title":"Oncol. Res"},{"issue":"246","key":"10.1016\/j.biopha.2021.111990_bib67","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1600-065X.2012.01099.x","article-title":"NF-\u03baB and the link between inflammation and cancer","volume":"2012","author":"DiDonato","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biopha.2021.111990_bib68","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1128\/MCB.21.4.1024-1035.2001","article-title":"Shared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and IkappaBalpha","volume":"21","author":"Heissmeyer","year":"2001","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2021.111990_bib69","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.immunol.14.1.649","article-title":"The NF-kappa B and I kappa B proteins: new discoveries and insights","volume":"14","author":"Baldwin","year":"1996","journal-title":"Annu Rev. Immunol."},{"key":"10.1016\/j.biopha.2021.111990_bib70","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri.2017.142","article-title":"NF-\u03baB, inflammation, immunity and cancer: coming of age","volume":"18","author":"Taniguchi","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2021.111990_bib71","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.4049\/jimmunol.171.6.3278","article-title":"Betulinic acid suppresses carcinogen-induced NF-kappa B activation through inhibition of I kappa B alpha kinase and p65 phosphorylation: abrogation of cyclooxygenase-2 and matrix metalloprotease-9","volume":"171","author":"Takada","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2021.111990_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173493","article-title":"Betulinic acid inhibits cell proliferation and migration in gastric cancer by targeting the NF-\u03baB\/VASP pathway","volume":"889","author":"Chen","year":"2020","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2021.111990_bib73","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.clml.2017.09.010","article-title":"Cellular proliferation by multiplex immunohistochemistry identifies high-risk multiple myeloma in newly diagnosed, treatment-naive patients","volume":"17","author":"Ely","year":"2017","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.biopha.2021.111990_bib74","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1200\/JCO.2016.69.0032","article-title":"Cell-Cycle therapeutics come of age","volume":"35","author":"Ingham","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2021.111990_bib75","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12943-016-0558-7","article-title":"Caveolin-1 in the regulation of cell metabolism: a cancer perspective","volume":"15","author":"Nwosu","year":"2016","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2021.111990_bib76","first-page":"1039","article-title":"Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors","volume":"14","author":"La Rosa","year":"1994","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2021.111990_bib77","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.biopha.2021.111990_bib78","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.biopha.2021.111990_bib79","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bcp.2019.01.016","article-title":"Betulinic acid suppresses breast cancer aerobic glycolysis via caveolin-1\/NF-\u03baB\/c-Myc pathway","volume":"161","author":"Jiao","year":"2019","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.biopha.2021.111990_bib80","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1053\/j.gastro.2017.03.035","article-title":"SP and KLF transcription factors in digestive physiology and diseases","volume":"152","author":"Kim","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2021.111990_bib81","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1093\/gbe\/evv141","article-title":"KLF\/SP transcription factor family evolution: expansion, diversification, and innovation in eukaryotes","volume":"7","author":"Presnell","year":"2015","journal-title":"Genome Biol. Evol."},{"key":"10.1016\/j.biopha.2021.111990_bib82","doi-asserted-by":"crossref","first-page":"24428","DOI":"10.1074\/jbc.M503790200","article-title":"Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells","volume":"280","author":"Begon","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2021.111990_bib83","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1093\/nar\/26.16.3776","article-title":"Cloning, chromosomal localization and promoter analysis of the human transcription factor YY1","volume":"26","author":"Yao","year":"1998","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2021.111990_bib84","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrc.2016.18","article-title":"Radiation oncology in the era of precision medicine","volume":"16","author":"Baumann","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2021.111990_bib85","first-page":"389","article-title":"Progress and controversies: Radiation therapy for prostate cancer","volume":"64","author":"Martin","year":"2014","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2021.111990_bib86","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.3892\/or.2017.5872","article-title":"Betulinic acid increases radiosensitization of oral squamous cell carcinoma through inducing Sp1 sumoylation and PTEN expression","volume":"38","author":"Yuan","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2021.111990_bib87","first-page":"iv1","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012","volume":"4","author":"Ostrom","year":"2015","journal-title":"Neuro Oncol. Issue suppl_"},{"key":"10.1016\/j.biopha.2021.111990_bib88","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.5966\/sctm.2014-0086","article-title":"Intercellular cooperation and competition in brain cancers: lessons from Drosophila and human studies","volume":"3","author":"Waghmare","year":"2014","journal-title":"Stem Cells Transl. Med"},{"key":"10.1016\/j.biopha.2021.111990_bib89","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.redox.2017.08.005","article-title":"Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O 6-methylguanine-DNA methyltransferase","volume":"13","author":"Chang","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2021.111990_bib90","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3390\/cancers12040981","article-title":"Betulinic Acid-Mediated Tuning of PERK\/CHOP signaling by Sp1 inhibition as a novel therapeutic strategy for glioblastoma","volume":"12","author":"Lo","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2021.111990_bib91","first-page":"98","article-title":"Betulinic acid inhibits stemness and EMT of pancreatic cancer cells via activation of AMPK signaling","volume":"54","author":"Sun","year":"2019","journal-title":"Int J. Oncol."},{"key":"10.1016\/j.biopha.2021.111990_bib92","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/tox.22621","article-title":"Effects and mechanisms of betulinic acid on improving EGFR TKI-resistance of lung cancer cells","volume":"33","author":"Ko","year":"2018","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.biopha.2021.111990_bib93","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/JTO.0000000000000033","article-title":"A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non\u2010small\u2010cell lung cancer of adenocarcinoma histology (PIONEER)","volume":"9","author":"Shi","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.biopha.2021.111990_bib94","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1056\/NEJMoa1609324","article-title":"Long-term outcomes of imatinib treatment for chronic myeloid leukemia","volume":"376","author":"Hochhaus","year":"2017","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2021.111990_bib95","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification","volume":"293","author":"Gorre","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.biopha.2021.111990_bib96","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1038\/leu.2017.144","article-title":"HDAC3 regulates DNMT1 expression in multiple myeloma: therapeutic implications","volume":"31","author":"Harada","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.biopha.2021.111990_bib97","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.molonc.2012.07.003","article-title":"Histone deacetylases and cancer","volume":"6","author":"Barneda-Zahonero","year":"2012","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.biopha.2021.111990_bib98","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/nyas.14298","article-title":"Betulinic acid restores imatinib sensitivity in BCR-ABL1 kinase-independent, imatinib-resistant chronic myeloid leukemia by increasing HDAC3 ubiquitination and degradation","volume":"1467","author":"Lu","year":"2020","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.biopha.2021.111990_bib99","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/222385a0","article-title":"Platinum compounds: a new class of potent antitumour agents","volume":"26","author":"Rosenberg","year":"1969","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2021.111990_bib100","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1208876","article-title":"Repurposing platinum-based chemotherapies for multi-modal treatment of glioblastoma","volume":"5","author":"Roberts","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.biopha.2021.111990_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108841","article-title":"Evaluation of the betulinic acid-cisplatin conjugate apc and its precursor de9b for the treatment of human malignant glioma","volume":"314","author":"Bache","year":"2019","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.biopha.2021.111990_bib102","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/cbdd.12682","article-title":"Betulinic Acid: Recent Advances in Chemical Modifications, Effective Delivery, and Molecular Mechanisms of a Promising Anticancer Therapy","volume":"87","author":"Ali-Seyed","year":"2016","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.biopha.2021.111990_bib103","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopha.2017.01.034","article-title":"Betulinic acid promotes TRAIL function on liver cancer progression inhibition through p53\/Caspase-3 signaling activation","volume":"88","author":"Xu","year":"2017","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2021.111990_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217718","article-title":"Study of the potential adverse effects caused by the dermal application of Dillenia indica L. fruit extract standardized to betulinic acid in rodents","volume":"14","author":"Fernandes","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2021.111990_bib105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1055\/s-0043-123472","article-title":"New pharmacological opportunities for betulinic acid","volume":"84","author":"R\u00edos","year":"2018","journal-title":"Planta Med"},{"key":"10.1016\/j.biopha.2021.111990_bib106","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1517\/13543776.2014.927441","article-title":"Betulinic acid and its derivatives: a patent review (2008-2013)","volume":"24","author":"Csuk","year":"2014","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.biopha.2021.111990_bib107","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.3892\/or.2020.7787","article-title":"Effects and mechanisms of fatty acid metabolism-mediated glycolysis regulated by betulinic acid-loaded nanoliposomes in colorectal cancer","volume":"44","author":"Wang","year":"2020","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2021.111990_bib108","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: the next paradigm in drug discovery","volume":"4","author":"Hopkins","year":"2008","journal-title":"Nat. Chem. Biol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221007733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221007733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:28:26Z","timestamp":1760099306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221007733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":108,"alternative-id":["S0753332221007733"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111990","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Betulinic acid in the treatment of tumour diseases: Application and research progress","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111990","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111990"}}